Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment

    December 2007 in “ Primary Care ”
    Walter Futterweit
    Image of study
    TLDR Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.
    The document from 2007 highlights Polycystic Ovary Syndrome (PCOS) as a common endocrine disorder affecting 5% to 10% of women of reproductive age, with significant reproductive and metabolic implications. It underscores the necessity of early diagnosis and treatment to reduce the emotional impact of symptoms such as acne, hirsutism, alopecia, and infertility, and to lower the risk of serious health issues like type 2 diabetes mellitus (T2DM), strokes, and myocardial infarction. The document details the pathogenesis of PCOS, its clinical manifestations, and the criteria for diagnosis, noting that 50% to 75% of women with the condition remain undiagnosed. It also discusses the association between PCOS and insulin resistance, metabolic syndrome, and cardiovascular diseases, emphasizing the importance of screening for these comorbidities. Treatment options mentioned include lifestyle modifications, pharmacotherapy with drugs like metformin and thiazolidinediones, and the management of cosmetic concerns with anti-androgen treatments. The document calls for comprehensive evaluation and treatment to manage PCOS and its associated risks, while acknowledging the need for more long-term outcome data on metabolic interventions for PCOS.
    Discuss this study in the Community →

    Research cited in this study

    12 / 12 results

    Related Community Posts Join

    6 / 1000+ results

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  53 upvotes 2 years ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community How does hair loss and recovery work?

      in Chat  12 upvotes 1 year ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community Bile Acid-Mediated DHT Dysregulation Hypothesis

      in Research/Science  13 upvotes 1 year ago
      Elevated bile acids can inhibit the enzyme AKR1C2, leading to increased DHT levels, which may accelerate hair loss in those predisposed to androgenetic alopecia. Treatments mentioned include topical minoxidil and finasteride.

      community DHT levels after 4 weeks of Fina and 8 weeks of Fina + 4 weeks of Duta

      in Update  34 upvotes 6 years ago
      The user reported early stage diffuse hair thinning and increased DHT levels after 4 weeks on Finasteride and 8 weeks on Finasteride plus 4 weeks on Dutasteride, despite the medications being authentic and stored properly. They are considering increasing their Dutasteride dosage due to the lack of side effects and are unsure if the treatment is helping their hair.

      community Recovered from dark finasteride side effects

      in Finasteride/Dutasteride  6 upvotes 4 years ago
      The user experienced severe side effects from finasteride, including depression and anxiety, but recovered with DHT injections, sleep medication, and Ayurvedic treatments. They now maintain hair health with minoxidil, PRP therapy, and a good diet, advising against self-diagnosis and recommending consulting a doctor.

    Related Research

    1 / 1 results